Home › Bids
› First in Human and Early Stage Clinical Trials of Novel Inve
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
This grant opportunity (PAR-25-180) from NIH supports first-in-human and early-stage clinical trials of novel investigational drugs or neuromodulatory device-based interventions for psychiatric disorders. A U01 clinical trial is required, and the CFDA number is 93.242.
Want the full details?
Sign up free to see the agency name and the original bid posting link, plus contracting-officer contacts and AI response outlines. Every feature is free through December 31, 2026.